Inhibition of apoptosis by knockdown of caspase-3 with siRNA in rat bone marrow mesenchymal stem cells

Experimental Biology and Medicine

Volumn 238, Issue 9, 2013, Pages 991-998

  Hua, Ping ^a   Liu, Li bao ^a   Liu, Jia liang ^a   Wang, Meng ^a   Jiang, Hui qi ^a   Zeng, Kuan ^a   Yang, Yan qi ^a   Yang, Song ran ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

BMSC; Cell therapy; myocardial infarction; oxidative stress; stable transfection

Indexed keywords

BETA1 INTEGRIN; CASPASE 3; CD71 ANTIGEN; GREEN FLUORESCENT PROTEIN; HERMES ANTIGEN; HYDROGEN PEROXIDE; LIPOSOME; MESSENGER RNA; SMALL INTERFERING RNA; THY 1 ANTIGEN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL EXPANSION; CELL SEPARATION; CELL STRUCTURE; CELL SURVIVAL; CELL TRANSFER; CELL VIABILITY; CONTROLLED STUDY; DNA MODIFICATION; GENE SEQUENCE; HEMATOPOIETIC STEM CELL; IN VITRO GENE TRANSFER; IN VITRO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BMSC; CELL THERAPY; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; STABLE TRANSFECTION;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; CASPASE 3; CELL CULTURE TECHNIQUES; GENE KNOCKDOWN TECHNIQUES; MESENCHYMAL STROMAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84884271419     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370213497320     Document Type: Article

References (23)

1. Wang JS,Shum-Tim D,Galipeau J,Chedrawy E,Eliopoulos N,Chiu RC.Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages.J Thorac Cardiovasc Surg. 2000;120:999-1005.
2. Hassan F,Meduru S,Taguchi K,Kuppusamy LM,Mostafa M,Kuppusamy P,Khan M.Carvedilol enhances mesenchymal stem cell therapy for myocardial infarction via inhibition of caspase-3 expression.J Pharmacol Exp Ther. 2012;343:62-71.
3. Daniel PT.Dissecting the pathways to death.Leukemia. 2000;14:2035-44.
4. Chong AY,Caine GJ,Lip GY.Angiopoietin/tie-2 as mediators of angiogenesis: a role in congestive heart failure?.Eur J Clin Invest. 2004;34:9-13.
5. Contreras JL,Vilatoba M,Eckstein C,Bilbao G,Anthony TJ,Eckhoff DE.Caspase-8 and caspase-3 small interfering RNA decreases ischemia/reperfusion injury to the liver in mice.Surgery. 2004;136:390-400.
6. Liu CF,Jin LH.Influence of RNA interference for caspase-3 gene on cardiomyocyte apoptosis induced by hypoxia.Pract J Cardiac Cereb Pneumal Vasc Dis. 2008;6:.
7. Elbashir SM,Harborth J,Lendeckel W,Yalcin A,Weber K,Tuschl T.Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.Nature. 2001;411:494-8.
8. Elbashir SM,Harborth J,Weber K,Tuschl T.Analysis of gene function in somatic mammalian cells using small interfering RNAs.Methods. 2002;26:199-213.
9. Xie X,Sun A,Zhu W,Huang Z,Hu X,Jia J,Zou Y,Ge J.Transplantation of mesenchymal stem cells preconditioned with hydrogen sulfide enhances repair of myocardial infarction in rats.Tohoku J Exp Med. 2012;226:29-36.
10. Zeng X,Yu SP,Taylor T,Ogle M,Wei L.Protective effect of apelin on cultured rat bone marrow mesenchymal stem cells against apoptosis.Stem Cell Res. 2012;8:357-67.
11. Wei H,Li Z,Hu S,Chen X,Cong X.Apoptosis of mesenchymal stem cells induced by hydrogen peroxide concerns both endoplasmic reticulum stress and mitochondrial death pathway through regulation of caspases, p38 and JNK.J Cell Biochem. 2010;111:967-78.
12. Hampton MB,Orrenius S.Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis.FEBS Lett. 1997;414:552-6.
13. Herzog EL,Chai L,Krause DS.Plasticity of marrow-derived stem cells.Blood. 2003;15:3483-93.
14. Iwanaga K,Takano H,Ohtsuka M,Hasegawa H,Zou Y,Qin Y,Odaka K,Hiroshima K,Tadokoro H,Komuro I.Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine.Biochem Biophys Res Commun. 2004;325:1353-9.
15. Flynn A,O'Brien T.Stem cell therapy for cardiac disease.Expert Opin Biol Ther. 2011;11:177-87.
16. Martin-Rendon E,Brunskill SJ,Hyde CJ,Stanworth SJ,Mathur A,Watt SM.Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review.Eur Heart J. 2008;29:1807-18.
17. Hu X,Yu SP,Fraser JL,Lu Z,Ogle ME,Wang JA,Wei L.Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis.J Thorac Cardiovasc Surg. 2008;135:799-808.
18. Mangi AA,Noiseux N,Kong D,He H,Rezvani M,Ingwall JS,Dzau VJ.Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts.Nat Med. 2003;9:1195-201.
19. Li RK,Mickle DA,Weisel RD,Rao V,Jia ZQ.Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury.Ann Thorac Surg. 2001;72:1957-63.
20. Wisel S,Khan M,Kuppusamy ML,Mohan IK,Chacko SM,Rivera BK,Sun BC,Hideg K,Kuppusamy P.Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression.J Pharmacol Exp Ther. 2009;329:543-50.
21. Muller-Ehmsen J,Krausgrill B,Burst V,Schenk K,Neisen UC,Fries JW,Fleischmann BK,Hescheler J,Schwinger RH.Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction.J Mol Cell Cardiol. 2006;41:876-84.
22. Lee K,Majumdar MK,Buyaner D,Hendricks JK,Pittenger MF,Mosca JD.Human mesenchymal stem cells maintain transgene expression during expansion and differentiation.Mol Ther. 2001;3:857-66.
23. Jabbarzadeh E,Starnes T,Khan YM,Jiang T,Wirtel AJ,Deng M,Lv Q,Nair LS,Doty SB,Laurencin CT.Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: a combined gene therapy-cell transplantation approach.Proc Natl Acad Sci USA. 2008;105:11099-104.